Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
  • Price (EUR)34.40
  • Today's Change0.20 / 0.58%
  • Shares traded0.00
  • 1 Year change18.62%
  • Beta1.4630
Data delayed at least 15 minutes, as of Dec 03 2020 14:32 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. Its U.S. Facilities include approximately 224 behavioral healthcare facilities with approximately 9,500 beds in 40 states and Puerto Rico. The Company’s U.K. Facilities include approximately 361 behavioral healthcare facilities with approximately 8,700 beds in the United Kingdom. The Company operates a network of approximately 588 behavioral healthcare facilities with approximately 18,200 beds in 40 states, the United Kingdom and Puerto Rico.

  • Revenue in USD (TTM)3.15bn
  • Net income in USD100.29m
  • Incorporated2005
  • Employees28.40k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.